BlueRock Therapeutics will utilize Rune Labs’ StriveStudy clinical trial platform and FDA-cleared Apple Watch data-collection tool to monitor Parkinson’s disease.
Rune Labs partners with biopharma company for Parkinson’s research
BlueRock Therapeutics will utilize Rune Labs’ StriveStudy clinical trial platform and FDA-cleared Apple Watch data-collection tool to monitor Parkinson’s disease.
